It is based on a combination of ICC and IF where specific markers for CTC, such as CK and EpCAM are linked to nuclear and leukocyte staining CSS has been validated in a broad clinical testing program. This evidence concerns the gene EPCAM and intrahepatic cholangiocarcinoma.